International Pharmaceutical Industry : Marketing, And Sale Of Drugs For The Treatment Of Disorders Essay

Polypharmacy, described as an individual taking more than four medications, can be concerning with the aging population. Polypharmacy concerns include adverse drug reactions, drug interactions, higher cost, decreased mobility, decreased quality of life and cognition impairment. Those at greater risk of negative polypharmacy consequences include elderly, psychiatric patients, recently hospitalized, individuals with multiple doctors or pharmacies and people with impaired vision or dexterity. There are times that polypharmacy is at times needed to help a person with their diagnosis, an example of this is using multiple medications to treat congestive heart failure which can include digoxin, diuretics, and angiotensin-converting enzyme inhibitors

"In the past two decades or so, health care has been commercialized as never before, and professionalism in medicine seems to be giving way to entrepreneurialism," commented Arnold S. Relman, professor of medicine and social medicine at Harvard Medical School (Wekesser 66). This statement may have a great deal of bearing on reality. The tangled knot of insurers, physicians, drug companies, and hospitals that we call our health system are not as unselfish and focused on the patients' needs as people would like to think. Pharmaceutical companies are particularly ruthless, many of them spending millions of dollars per year to convince doctors to prescribe their drugs and to convince consumers that their specific brand of drug is needed in

Specify the types of country risks that pharmaceutical firms face in international business. How do the political and legal systems of countries affect the global pharmaceutical industry?

We in America tend to take medications for almost any problem we have, from headaches to gastrointestinal pain, to more serious chronic disorders such as depression and attention deficit disorder. While many of the uses of such medications may be necessary and legitimate, many are not, and due to this fact, many people become dependent on medications, mentally, and or physically. This problem is not simply the fault of the individual; in fact, the blame can also be placed upon the medical community, and the pharmaceutical companies who produce the drugs. How often can one turn on the television to see advertisements for Claritin, Aspirin, Pepto-Bismol, or even Zoloft or Ritalin? The pharmaceutical industry is motivated by monetary

Patients are intrigued by the idea that a medication will actually fight for them and be a powerful ally, in comparison to their current treatment that does “just enough” to get them by. They can

In the video Escape Fire, I was so flabbergasted by the numbers and health outcomes we as a society have let our nation become. One of the most heart-wrenching evidence is, even though our health care industry is so expensive our health outcomes are the worse. 75% of disabilities and dead’s are preventable, according to the film.

First, the medical assistant should convert the doctor’s prescription into layman’s terms for Doris. Medication A is two teaspoons by mouth every four hours. Medication B is 2.5 milliliters by mouth three times daily (Fulcher, Fulcher, & Soto, 2012, p. 1b). Doris should be cautious of confusing her medication dosages as that could lead to possible overdose. If Doris is afraid of mixing her medications, the medical assistant should convert to the unit that Doris is more comfortable with. For example, if Doris prefers milliliters, she should take around 9.8 milliliters of medication A. Alternatively, medication B could be taken at .5 teaspoons (Fulcher, Fulcher, & Soto, 2012, p. 131). Patients taking multiple medications should have a medication

Market failure appears when there is a failure in allocation of goods and services. When the market is unsuccessful, the government is called to intervene and correct the failure. Over the years, government participation in the pharmaceutical market has been more wide-ranging than any other good or service. With the government’s ability to regulate, mandate, inform, finance and provide, their intervention to overcome market failure can be beneficial for the economy. Market failure plays a significant role in today’s economy.

People all over the world, continue to be tendered prescription medication, which in many cases further complicate health issues with its myriad of side effects. In fact, statistics have shown that approximately 100,000 people around the world die as a result of prescription drugs annually (Smith, 2012). On the contrary, according

Prescription drug prices are increasing and it is becoming much more difficult for people that rely on healthcare to purchase them. Branded prescription drugs, specialty prescription drugs, and even generic products like ibuprofen have been inflating in the last 7 years. There are a number of reasons to attribute to the said inflation over the last 7 years. Newly approved branded and specialty prescription drugs and the rising costs of existing branded and specialty prescription drugs.

During medical school I became very passionate about neurodegenerative diseases and as such, I have pursued a postdoctoral fellowship at Western. My experiences and knowledge have led me to not only find the pathophysiology of neurodegenerative diseases but to find new potential treatments; one of which is a potential patentable new medication. Both these experiences have taught me a lot in regards to the wide and complex field of medicine. I have learned the rigorous work it takes to do research as the business side of research. I believe innovations such as these, will open doors for healthcare providers to do their jobs effectively and efficiently, which improves the patient’s quality of life and

“In 1987, the Government of Canada launched a 5-year, $210 million dollar strategy, the National Drug Strategy, to address concerns related to drug abuse in Canada. Recognizing that a balanced approach was needed, the strategy addressed both the supply and the demand sides of the problem (Collin, 2006.)”

Yes, there is an impact on the pharmaceutical company, like those in the US as a result of differential prices between that country and other nations.

This report provides an analytical strategic review of the global pharmaceutical industry; its origin, evolution,

Solution: Creating autonomous teams that don’t report into the organization but report to the top management. Co-locate with the local biotech ecosystem. Second, give time bound budgets.